CONNECTING THE DEFENCE COMMUNITY WITH INSIGHT, INTELLIGENCE & OPPORTUNITIES

Officially Supported By: Defence Contracts International Supply2Defence

Official Media Partners for:

Scientists from the Naval Medical Research Center believe a common antibiotic could relieve the symptoms of decompression sickness.

Naval Medical Research Center (NMRC) scientists believe common antibiotic doxycycline could be used to treat decompression sickness in divers. During a presentation at the Military Health System Research Symposium (MHSRS) in Florida, scientists explained how doxycycline supplement therapy, along with recompression therapy, could reduce disease associated with decompression sickness among Navy personnel.

Decompression sickness (DCS) is a major risk for Navy divers and operators of Diving and Disabled Submarine Rescue (DISSUB) vessels. The presentation looked at how doxycycline affects three factors – mortality, the occurrence of cardiovascular and neurologic DCS, and the time to death based on cardiovascular and neurological DCS.

Undersea Medical Officer Lieutenant Rainey Johnson said: “DCS is an ever-present risk in operational diving and DISSUB scenarios. While recompression therapy is the gold standard for treating DCS, adequate chamber capacity might not be available during operations with a large number of casualties, or in remote locations, and DISSUB rescuees might need to transfer to recompression chambers at surface pressures. Considering these factors we chose to try a common and inexpensive FDA approved antibiotic. In this case Doxycycline, to give divers better treatment and time. The drug prevents DCS severity by inhibiting matrix metalloproteinases and modifying leukocyte responses.”

“Time to these events are important as increased inactivity allow for additional life saving measures to occur. Adjusting study effect is essential for multiple studies analysis. Future studies are underway incorporating doxycycline prophylaxis in a simulated DISSUB scenario decompressed from saturation. If worthwhile, the results from this and the follow on studies will be communicated to NAVSEA to support submarine rescue in the event of a DISSUB scenario.”

Scientists concluded that doxycycline reduced mortality rates but not by a significant amount. DCS is most effectively treated if the sufferer receives treatment early on, especially in more serious cases of injury.

If you would like to join our community and read more articles like this then please click here.

Post written by: Ciara Houghton


LATEST STAKEHOLDER

Become a Stakeholder today and benefit from an exclusive marketing package which will allow you to:

  • Engage with active defence buyers and key supply chain partners
  • Create your own branded micro-site which within Defence Online which is managed by you
  • Have a dedicated Digital Account Manager to help enhance your Stakeholder page
  • Promote your news, products, press releases, eBooks and Videos as a Defence Online partner which feeds through to our homepage and social media channels
  • Have your company promoted on our partner website Defence Contracts Online (DCO)
  • All news promoted in mynewsdesk, a major hub for all of our news articles which enables news to be picked up from trade magazines, national newspapers and many other publications which offers extra exposure at no additional cost!

Contact us today or call us on 0845 557 1315 to take advantage of this exclusive marketing package


.

RELATED ARTICLES

Do you have an innovative idea to enhance the detection of trace explosives using novel, lightweight, bioassay systems?

April 19, 2024

Land - X marks the spot for bomb disposal tech

X-ray backscatter imaging is increasingly used in combat zones to identify the presence of explosives and weapons. However, advanced systems

Turner & Townsend has been appointed by global security and aerospace company, BAE Systems, as the New Engineering Contract (NEC) Project Manager to support the delivery of Ship Build Hall in Glasgow, Scotland.

April 18, 2024

Maritime - Glasgow Ship Build Hall progress

Turner & Townsend has been appointed by global security and aerospace company, BAE Systems, as the New Engineering Contract (NEC)